生命科学资讯

Bristol Myers and Evinova pen global development partnership

FDA rejects Regenxbio's gene therapy in Hunter syndrome, leaving CEO 'concerned'

Waters Corporation (NYSE:WAT) Reports Q4 CY2025 In Line With Expectations - TradingView

Waters Corporation (NYSE:WAT) Reports Q4 CY2025 In Line With Expectations - Yahoo! Finance Canada

FDA rejects Regenxbio's Hunter syndrome gene therapy

With scant data, RFK Jr. credits Trump for higher European drug prices

FDA slaps highest-risk recall notice on J&J Medtech Cerepak detachable coils

QuantX raises $85M Series B from Lilly, Sanofi Ventures

Lilly buys ‘in vivo’ CAR-T maker Orna, extending streak of genetic medicine deals

Appointments and advancements for Feb. 9, 2026

Financings for Feb. 9, 2026

In the clinic for Feb. 9, 2026

Other news to note for Feb. 9, 2026

Regulatory actions for Feb. 9, 2026

Despite FDA’s crackdown, pharma is still spending millions on ads

Takeda inks $1.7B AI drug discovery deal with Iambic Therapeutics

Lilly buys Orna in $2.4B deal to enter in vivo CAR-T arena

Lilly bets again on China drugs; Roche showcases MS data

Thermo Fisher Scientific Inc files for four-part senior notes offering size not disclosed - marketscreener.com

Lilly joins in vivo CAR-T sprint with $2.4B Orna acquisition